Alkeon Capital Management’s IGM Biosciences IGMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-711,777	Closed	-$9.78M	–	127
2023 Q1	$9.78M	Sell	711,777 -121,464	-15%	-$2.51M	0.06%	112
2022 Q4	$14.2M	Sell	833,241 -128,372	-13%	-$2.57M	0.11%	111
2022 Q3	$21.9M	Sell	961,613 -72,422	-7%	-$1.46M	0.15%	113
2022 Q2	$18.6M	Hold	1,034,035	–	–	0.11%	116
2022 Q1	$27.6M	Buy	1,034,035 +95,000	+10%	+$1.77M	0.12%	121
2021 Q4	$27.5M	Sell	939,035 -9,762	-1%	-$485K	0.09%	120
2021 Q3	$62.4M	Sell	948,797 -102,632	-10%	-$7.85M	0.21%	108
2021 Q2	$87.5M	Sell	1,051,429 -2,123	-0.2%	-$157K	0.31%	107
2021 Q1	$80.8M	Buy	1,053,552 +2,568	+0.2%	+$234K	0.31%	106
2020 Q4	$92.8M	Buy	1,050,984 +122,184	+13%	+$8.59M	0.35%	101
2020 Q3	$68.6M	Buy	928,800 +175,000	+23%	+$10.4M	0.32%	95
2020 Q2	$55M	Buy	753,800 +270,200	+56%	+$16.4M	0.29%	96
2020 Q1	$27.2M	Buy	+483,600	New	+$21.2M	0.22%	99